Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Puromycin-sensitive aminopeptidase (PSA), also known as cytosol alanyl aminopeptidase or alanine aminopeptidase (AAP), is a zinc-dependent metallopeptidase encoded by the NPEPPS gene in humans. It plays a key role in degrading neuroactive peptides and is involved in the final steps of intracellular peptide hydrolysis. Elevated levels are detected in urine during kidney damage. Upregulation has been observed in platinum-resistant bladder cancer cells, and inhibition sensitizes tumors to cisplatin.
Inhibition of N-terminal amino acid removal from peptides, Sensitizes tumors to cisplatin
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Puromycin-sensitive aminopeptidase (PSA).